Everolimus 60219-2280-02
- Manufacturer
- Amneal Pharmaceuticals Ny Llc
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 14, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA218863
Need to source Everolimus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Everolimus | 3 mg/1 |
Drug Class
Kinase Inhibitor [EPC]mTOR Inhibitor Immunosuppressant [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
60219-2280-02Selected4 BLISTER PACK in 1 CARTON (60219-2280-2) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (60219-2280-1)